Precision BioSciences Inc
NASDAQ:DTIL
Precision BioSciences Inc
NASDAQ:DTIL
Price:
6.52
USD
-2.98%
Market Closed
Market Cap:
$161.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Precision BioSciences Inc
NASDAQ:DTIL
|
US |
|
T
|
Thor Mining PLC
OTC:THORF
|
UK |
|
H
|
HD Renewable Energy Co Ltd
TWSE:6873
|
TW |
|
E
|
Energy Fuels Inc
AMEX:UUUU
|
US |
|
P
|
Pebble Beach Systems Group PLC
LSE:PEB
|
UK |
|
First Bancshares Inc (Missouri)
OTC:FBSI
|
US |
|
S
|
Sphere Entertainment Co
NYSE:SPHR
|
US |
|
NavInfo Co Ltd
SZSE:002405
|
CN |
|
Camtek Ltd
NASDAQ:CAMT
|
IL |
|
U
|
Universal Global Hub Inc
OTC:UGHB
|
US |
|
United Bancorp Inc
NASDAQ:UBCP
|
US |
|
D
|
DISH Network Corp
LSE:0IBG
|
US |
|
G
|
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
|
CN |
|
Kanpur Plastipack Ltd
NSE:KANPRPLA
|
IN |
Relative Value
The Relative Value of one
DTIL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 6.52 USD,
Precision BioSciences Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DTIL Relative Value
HIDDEN
Multiples Across Competitors
DTIL Competitors Multiples
Precision BioSciences Inc Competitors
Precision BioSciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Precision BioSciences Inc
NASDAQ:DTIL
|
157.1m USD | 4.6 | -3.4 | -1.3 | -1.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
